Dr Daniel David Tarver, MD | |
310 N 10th St, Bismarck, ND 58501-4516 | |
(701) 530-7500 | |
(701) 530-7484 |
Full Name | Dr Daniel David Tarver |
---|---|
Gender | Male |
Speciality | Interventional Radiology |
Experience | 16 Years |
Location | 310 N 10th St, Bismarck, North Dakota |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1679746218 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | 042.0012663 (Vermont) | Primary |
2085R0204X | Radiology - Vascular & Interventional Radiology | 042.0012663 (Vermont) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Sanford Medical Center Bismarck | Bismarck, ND | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Sanford Bismarck | 9739098575 | 448 |
News Archive
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it has immunized its first subject in a U.S. Phase I clinical trial to evaluate its SynCon™ H5N1 (avian) influenza DNA vaccine, VGX-3400X.
Anesthesia providers can and should begin taking steps toward practicing "sustainable anesthesia," according to the May special issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.
Uniqsis has introduced FlowLab Column – an optimized flow chemistry system for heterogeneous catalysis applications.
Today, Sekisui Diagnostics announces the launch of three new rapid tests as additions to the OSOM portfolio. Providing accurate results with minimal hands on time, OSOM Ultra Flu A&B and OSOM Ultra hCG Combo complement the existing Flu and hCG product lines, while the OSOM iFOB provides a new diagnostic option for fecal occult blood testing.
A team of researchers at Emory University and the Georgia Institute of Technology believes the new microneedle skin patch method of delivering flu vaccine could improve overall seasonal vaccination coverage in people because of decreased pain, increased convenience, lower cost and simpler logistics over conventional hypodermic immunization.
› Verified 7 days ago
Entity Name | St Alexius Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1205868429 PECOS PAC ID: 8426960865 Enrollment ID: O20031104000146 |
News Archive
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it has immunized its first subject in a U.S. Phase I clinical trial to evaluate its SynCon™ H5N1 (avian) influenza DNA vaccine, VGX-3400X.
Anesthesia providers can and should begin taking steps toward practicing "sustainable anesthesia," according to the May special issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.
Uniqsis has introduced FlowLab Column – an optimized flow chemistry system for heterogeneous catalysis applications.
Today, Sekisui Diagnostics announces the launch of three new rapid tests as additions to the OSOM portfolio. Providing accurate results with minimal hands on time, OSOM Ultra Flu A&B and OSOM Ultra hCG Combo complement the existing Flu and hCG product lines, while the OSOM iFOB provides a new diagnostic option for fecal occult blood testing.
A team of researchers at Emory University and the Georgia Institute of Technology believes the new microneedle skin patch method of delivering flu vaccine could improve overall seasonal vaccination coverage in people because of decreased pain, increased convenience, lower cost and simpler logistics over conventional hypodermic immunization.
› Verified 7 days ago
Entity Name | Sanford Bismarck |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1811941172 PECOS PAC ID: 9739098575 Enrollment ID: O20031105000403 |
News Archive
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it has immunized its first subject in a U.S. Phase I clinical trial to evaluate its SynCon™ H5N1 (avian) influenza DNA vaccine, VGX-3400X.
Anesthesia providers can and should begin taking steps toward practicing "sustainable anesthesia," according to the May special issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.
Uniqsis has introduced FlowLab Column – an optimized flow chemistry system for heterogeneous catalysis applications.
Today, Sekisui Diagnostics announces the launch of three new rapid tests as additions to the OSOM portfolio. Providing accurate results with minimal hands on time, OSOM Ultra Flu A&B and OSOM Ultra hCG Combo complement the existing Flu and hCG product lines, while the OSOM iFOB provides a new diagnostic option for fecal occult blood testing.
A team of researchers at Emory University and the Georgia Institute of Technology believes the new microneedle skin patch method of delivering flu vaccine could improve overall seasonal vaccination coverage in people because of decreased pain, increased convenience, lower cost and simpler logistics over conventional hypodermic immunization.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Daniel David Tarver, MD Po Box 2698, Bismarck, ND 58502-2698 Ph: (701) 530-7500 | Dr Daniel David Tarver, MD 310 N 10th St, Bismarck, ND 58501-4516 Ph: (701) 530-7500 |
News Archive
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it has immunized its first subject in a U.S. Phase I clinical trial to evaluate its SynCon™ H5N1 (avian) influenza DNA vaccine, VGX-3400X.
Anesthesia providers can and should begin taking steps toward practicing "sustainable anesthesia," according to the May special issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.
Uniqsis has introduced FlowLab Column – an optimized flow chemistry system for heterogeneous catalysis applications.
Today, Sekisui Diagnostics announces the launch of three new rapid tests as additions to the OSOM portfolio. Providing accurate results with minimal hands on time, OSOM Ultra Flu A&B and OSOM Ultra hCG Combo complement the existing Flu and hCG product lines, while the OSOM iFOB provides a new diagnostic option for fecal occult blood testing.
A team of researchers at Emory University and the Georgia Institute of Technology believes the new microneedle skin patch method of delivering flu vaccine could improve overall seasonal vaccination coverage in people because of decreased pain, increased convenience, lower cost and simpler logistics over conventional hypodermic immunization.
› Verified 7 days ago
Michael J Mcintee, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 222 N 7th St, Bismarck, ND 58501 Phone: 701-323-6000 Fax: 701-323-5479 | |
Matthew Iwamoto, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 222 N 7th St, Bismarck, ND 58501 Phone: 701-323-6000 | |
Christina Marie Tello-skjerseth, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 222 N 7th St, Bismarck, ND 58501 Phone: 701-323-6000 | |
Joshua William Rampton, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 222 N 7th St, Bismarck, ND 58501 Phone: 701-323-5422 | |
Brian J Rau, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 222 N 7th St, Bismarck, ND 58501 Phone: 701-323-6000 Fax: 701-323-6249 | |
Kyle T Darras, FNP-C Radiology Medicare: Accepting Medicare Assignments Practice Location: 7500 University Dr, Bismarck, ND 58504 Phone: 701-355-3770 | |
Dr. Andrew James Wilder, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 401 N 9th St, Bismarck, ND 58501 Phone: 701-712-4251 Fax: 701-712-4272 |